Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels

Clinical trial NCT00083928 · COMPLETED

Trial details

NCT number: NCT00083928
Sponsor: Ångstrom Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Carcinoma

Start date: 2004-05-01
Primary completion: 2006-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.